QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma
- 14 May 2015
- journal article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 17 (4), 402-411
- https://doi.org/10.1016/j.jmoldx.2015.03.010
Abstract
No abstract availableKeywords
Funding Information
- The Christie Charity Lymphoma Research Fund
This publication has 49 references indexed in Scilit:
- Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomasBritish Journal of Haematology, 2013
- B-cell receptor signaling as a driver of lymphoma development and evolutionSeminars in Cancer Biology, 2013
- Pathogenetic importance and therapeutic implications of NF‐κB in lymphoid malignanciesImmunological Reviews, 2012
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaNature, 2010
- Stromal Gene Signatures in Large-B-Cell LymphomasThe New England Journal of Medicine, 2008
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-κB pathway as a target for new therapeutic strategiesLeukemia & Lymphoma, 2008
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaThe New England Journal of Medicine, 2002
- Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma CellsThe Journal of Experimental Medicine, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000